You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Progression-free survival (PFS)

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Radiotherapy Combined With EGFR-TKI for Stage III EGFR Mutant

Completed
  • The Primary Study Metric is Progression-free Survival (PFS)
    • (no location specified)
    Jun 28, 2023

    Progression Free Survival(PFS) Trial (Toposide capsules combined with anrotinib and Emvolizumab group)

    Not yet recruiting
    • Progression Free Survival(PFS)
    • Toposide capsules combined with anrotinib and Emvolizumab group
    • (no location specified)
    Jan 13, 2023

    free Survival and Evaluate Participant Experience for Metastatic

    Active, not recruiting
    • Anaplastic Lymphoma Kinase-positive
    • Carcinoma Non-small-cell Lung
    • Maynard, Massachusetts
      EmpiraMed, Inc.
    Feb 28, 2022

    Metastatic Prostate Cancer Trial (Darolutamide, Radium-223)

    Not yet recruiting
    • Metastatic Prostate Cancer
    • (no location specified)
    Mar 6, 2023

    Follicular Lymphoma, Small Lymphocytic Lymphoma, Marginal Zone Lymphoma Trial in United States (dietary supplement, biological,

    Active, not recruiting
    • Follicular Lymphoma
    • +3 more
    • Vitamin D
    • +2 more
    • Miami, Florida
    • +6 more
    Mar 6, 2022

    Progression-free Survival Trial (Sovalteinib Solutumab Tegeo)

    Not yet recruiting
    • Progression-free Survival
    • Sovalteinib Solutumab Tegeo
    • (no location specified)
    Jul 24, 2023

    Bladder Cancer, Bladder Urothelial Carcinoma Trial in Toronto (re-TURBT, 6 weeks BCG instillation)

    Terminated
    • Bladder Cancer
    • Bladder Urothelial Carcinoma
    • re-TURBT
    • 6 weeks BCG instillation
    • Toronto, Ontario, Canada
      University Health Network
    Apr 12, 2022

    Pancreatic Cancer, Thromboembolism Trial in Athens (Innohep, Chemotherapy: Gemcitabine + Nab-Paclitaxel)

    Recruiting
    • Pancreatic Cancer
    • Thromboembolism
    • Innohep
    • Chemotherapy: Gemcitabine + Nab-Paclitaxel
    • Athens, Attiki, Greece
    • +1 more
    Mar 28, 2022

    Progression Free Survival, Overall Survival, Maintenance Trial (Ixazomib DX/Lenalidomide DX)

    Not yet recruiting
    • Progression Free Survival
    • +2 more
    • Ixazomib DX/Lenalidomide DX
    • (no location specified)
    Jul 27, 2022

    Overall Survival, Progression-free Survival, Cost Trial (Microwave Ablation)

    Completed
    • Overall Survival
    • +2 more
    • Microwave Ablation
    • (no location specified)
    Apr 1, 2023

    Meningioma, Meningioma Atypical, Anaplastic Meningioma Trial in Rome (Biological biomarker assessment)

    Recruiting
    • Meningioma
    • +2 more
    • Biological biomarker assessment
    • Rome, Italy
      Fondazione Policlinico Universitario A. Gemelli IRCCS
    Mar 29, 2023

    Progression-free Survival, Gastrointestinal Stromal Tumor, Neoadjuvant Trial in Hangzhou (Imatinib)

    Recruiting
    • Progression-free Survival
    • +2 more
    • Hangzhou, Zhejiang, China
      The First Affiliated Hospital, College of Medicine, Zhejiang Uni
    Oct 9, 2021

    Breast Cancer Stage IV Trial in Mansoura (comparing both arms as regard the objective response rate, toxicity profile, quality

    Recruiting
    • Breast Cancer Stage IV
    • comparing both arms as regard the objective response rate, toxicity profile, quality of life, progression free survival
    • Mansoura, Dakahlia, Egypt
      Oncology center mansoura university
    Jan 1, 2023

    Colorectal Cancer, Chinese Herbal Medicine, Progression-free Survival Trial in China (Brucea javanica oil emulsion injection,

    Recruiting
    • Colorectal Cancer
    • +3 more
    • Brucea javanica oil emulsion injection
    • The best supportive treatment
    • Guangzhou, Guangdong, China
    • +3 more
    Jun 1, 2023

    Colorectal Cancer, Oligometastatic Disease Trial in Australia (Local Ablative Therapy, Standard first-line systemic treatment)

    Recruiting
    • Colorectal Cancer
    • Oligometastatic Disease
    • Local Ablative Therapy
    • Standard first-line systemic treatment
    • Albury, New South Wales, Australia
    • +8 more
    May 15, 2023

    Glioblastoma Trial in Toronto (Exercise)

    Completed
    • Glioblastoma
    • Exercise
    • Toronto, Ontario, Canada
      Princess Margaret Hospital, University Health Network
    Apr 13, 2022

    PD-1 Antibody and Radiotherapy for Recurrent Cervical Cancer

    Recruiting
    • Immune Checkpoint Inhibitors
    • +9 more
    • Radiotherapy for targeted lesions and PD-1 antibody
    • Beijing, Beijing, China
      Lei Li
    Apr 1, 2022

    Chromosomal Instability in Ovarian Cancer

    Recruiting
    • Epithelial Ovarian Cancer
    • +7 more
    • Testing for chromosomal instability (CIN)
    • Beijing, Beijing, China
      Lei Li
    Mar 26, 2022

    NSCLC Trial in Rozzano (Pemetrexed/Carboplatin, Gemcitabine)

    Terminated
    • NSCLC
    • Rozzano, Milan, Italy
      Istituto Clinco Humanitas
    Sep 8, 2022

    Dose Dense Chemotherapy in Elderly Patients > 80 Years Old With

    Completed
    • DLBCL
    • Old Age; Debility
      • Homburg, Saarland, Germany
        Saarland University Medical Center
      Nov 20, 2023

      Non-small Cell Lung Adenocarcinoma, Squamous Cell Carcinoma of Lung Trial in Guangzhou (SI-B001, Docetaxel)

      Not yet recruiting
      • Non-small Cell Lung Adenocarcinoma
      • Squamous Cell Carcinoma of Lung
      • Guangzhou, Guangdong, China
        Sun Yat-sen University Cancer Center
      Jul 5, 2023

      Glioma, Malignant, Glioblastoma, Glioblastoma Multiforme Trial in New York (Tissue autograft of pedicled temporoparietal fascial

      Recruiting
      • Glioma, Malignant
      • +6 more
      • Tissue autograft of pedicled temporoparietal fascial (TPF) or pericranial flap to bypass the blood brain barrier (BBB)
      • New York, New York
        Lenox Hill Brain Tumor Center
      Jul 13, 2023

      Hepatocellular Carcinoma Trial in Hangzhou (Fruquintinib, Sintilimab, Transcatheter arterial chemoembolization(TACE))

      Recruiting
      • Hepatocellular Carcinoma
      • Hangzhou, Zhejiang, China
        Guoliang Shao
      Aug 1, 2023

      Immunotherapy-related CRP Kinetics in Early and Metastatic

      Recruiting
      • TNBC - Triple-Negative Breast Cancer
        • Tuebingen, Germany
          Department of Women's Health
        Jun 13, 2023

        Multiple Myeloma Trial in Detroit, Charlotte (Carfilzomib, Ruxolitinib, Dexamethasone)

        Active, not recruiting
        • Multiple Myeloma
        • Detroit, Michigan
        • +1 more
        Jan 27, 2023